EPO and Alzheimer disease: The LTP-enhancing effect of EPO is particularly pertinent in diseases with prominent cognitive dysfunction such as Alzheimer’s disease (AD), where it rescues impaired LTP and memory deficits (Esmaeili Tazangi et al., 2015).